Jeffrey Gudin - Jan 31, 2022 Form 4/A - Amendment Insider Report for Virpax Pharmaceuticals, Inc. (VRPX)

Role
Chief Medical Officer, Director
Signature
/s/ Christopher Chipman, attorney-in-fact
Stock symbol
VRPX
Transactions as of
Jan 31, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
2/25/2022, 03:47 PM
Date Of Original Report
Feb 2, 2022
Next filing
Jan 27, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRPX Stock Option (right to buy) Award $0 +60.7K $0.00 60.7K Jan 31, 2022 Common Stock 60.7K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in three equal annual installments commencing on January 31, 2023.